Dexcom Inc
DXCM68.200USD
+0.020+0.03%
Close 10/30, 16:00（ET）Quotes delayed by 15 min
26.75BMarket Cap
46.80P/E TTM
More Details of Dexcom Inc Company
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Dexcom Inc Info
Ticker SymbolDXCM
Company nameDexcom Inc
IPO dateApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Number of employees10300
Security typeOrdinary Share
Fiscal year-endApr 14
Address6340 Sequence Dr
CitySAN DIEGO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code92121
Phone18582000200
Websitehttps://www.dexcom.com/
Ticker SymbolDXCM
IPO dateApr 14, 2005
CEOMr. Jacob Steven (Jake) Leach
Company Executives of Dexcom Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
276.26K
+6.52%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.33K
-12.01%
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Independent Director
Independent Director
28.04K
+21.94%
Mr. Kyle Malady
Mr. Kyle Malady
Independent Director
Independent Director
22.67K
-2.86%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Independent Director
Independent Director
9.04K
+127.87%
Ms. Renee D. Gala
Ms. Renee D. Gala
Independent Director
Independent Director
6.88K
+20.30%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
276.26K
+6.52%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
62.13K
+4.65%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
61.05K
+4.13%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
44.38K
+5.82%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
42.13K
+6.12%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.33K
-12.01%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Distributor
977.80M
84.50%
Direct
179.30M
15.50%
By RegionUSD
Name
Revenue
Proportion
United States
841.00M
72.68%
Outside of United states
316.10M
27.32%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Distributor
977.80M
84.50%
Direct
179.30M
15.50%
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Investment Management (US)
4.30%
Baillie Gifford & Co.
4.26%
Geode Capital Management, L.L.C.
2.75%
Other
70.24%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.28%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Investment Management (US)
4.30%
Baillie Gifford & Co.
4.26%
Geode Capital Management, L.L.C.
2.75%
Other
70.24%
Shareholder Types
Shareholders
Proportion
Investment Advisor
56.32%
Investment Advisor/Hedge Fund
28.54%
Research Firm
3.44%
Hedge Fund
3.01%
Pension Fund
2.02%
Bank and Trust
1.84%
Sovereign Wealth Fund
1.50%
Venture Capital
0.40%
Individual Investor
0.36%
Other
2.55%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2148
383.02M
97.67%
-30.18M
2025Q2
2212
390.97M
99.70%
-27.53M
2025Q1
2252
386.55M
98.59%
-25.17M
2024Q4
2220
380.88M
97.47%
-26.96M
2024Q3
2145
382.31M
97.83%
-30.58M
2024Q2
2115
397.02M
99.11%
-4.31M
2024Q1
2093
389.18M
98.33%
-19.87M
2023Q4
2081
398.01M
103.26%
+83.33K
2023Q3
1994
389.89M
100.89%
-11.88M
2023Q2
1952
389.17M
100.78%
-12.73M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
48.15M
12.28%
+859.71K
+1.82%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.25M
6.18%
-475.12K
-1.92%
Jun 30, 2025
State Street Investment Management (US)
16.86M
4.3%
+175.27K
+1.05%
Jun 30, 2025
Baillie Gifford & Co.
16.71M
4.26%
+2.53M
+17.81%
Jun 30, 2025
Geode Capital Management, L.L.C.
10.77M
2.75%
+358.62K
+3.45%
Jun 30, 2025
Jennison Associates LLC
11.52M
2.94%
+994.30K
+9.45%
Jun 30, 2025
Sands Capital Management, LLC
9.95M
2.54%
-466.21K
-4.48%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
8.03M
2.05%
-28.35K
-0.35%
Aug 31, 2025
Nuveen LLC
7.30M
1.86%
-549.07K
-7.00%
Jun 30, 2025
MFS Investment Management
6.49M
1.65%
+3.30M
+103.55%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
6.79%
Langar Global HealthTech ETF
5.33%
Global X Internet of Things ETF
5.24%
Global X HealthTech ETF
3.89%
Fidelity Digital Health ETF
3.79%
Harbor Health Care ETF
3.48%
iShares U.S. Medical Devices ETF
3.39%
Touchstone Sands Capital US Select Growth ETF
3.06%
Goldman Sachs Future Health Care Equity ETF
2.68%
Motley Fool Global Opportunities ETF
2.43%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion6.79%
Langar Global HealthTech ETF
Proportion5.33%
Global X Internet of Things ETF
Proportion5.24%
Global X HealthTech ETF
Proportion3.89%
Fidelity Digital Health ETF
Proportion3.79%
Harbor Health Care ETF
Proportion3.48%
iShares U.S. Medical Devices ETF
Proportion3.39%
Touchstone Sands Capital US Select Growth ETF
Proportion3.06%
Goldman Sachs Future Health Care Equity ETF
Proportion2.68%
Motley Fool Global Opportunities ETF
Proportion2.43%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 28, 2022
Split
1→4
Date
Type
Ratio
Mar 28, 2022
Split
1→4
